kodakbond -- Yes, the results from the hospitals you mention are in. And they are very positive (you can research this at FDA.gov/clinical trials). I am in emitf stock because of this. When (not if) the InSightec Exablate becomes the treatment of choice for ET, emitf stock should skyrocket. This may happen in weeks, months or years as neurosurgeons adopt this miracle treatment. Not incidentally, I will soon be having this procedure performed on myself (scheduled for April). I will report here how it comes out.